Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Gregory Pond

McMaster University

Canada

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Canada Professors in Biostatistics Biostatistics professors in Canada

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Collaborators (16)

Aly-Khan A. Lalani

McMaster University

CANADA

View details

Aaron R. Hansen

Medical Oncologist

University Health Network

CANADA

View details

Theodoros Tsakiridis

CANADA

View details

Christina Yap

Professor of Clinical Trials Biostatistics

Institute of Cancer Research

UNITED KINGDOM

View details

Fabio Ynoe Moraes

Assistant Professor - MD

Queen's University

CANADA

View details

Marie-France Savard

University of Ottawa

CANADA

View details

Darryl Leong

African Population and Health Research Center

CANADA

View details

Surbhi Sidana

Assistant Professor

Stanford University

UNITED STATES

View details

Hsien Seow

Associate Professor

McMaster University

CANADA

View details

Olalekan Lee Aiyegbusi

University of Birmingham

UNITED KINGDOM

View details

Gwynivere Davies

Hematologist, Associate Professor (McMaster University)

CANADA

View details

John Devin Peipert

Professor

University of Birmingham

UNITED KINGDOM

View details

Claire Snyder

Johns Hopkins University Bloomberg School of Public Health

UNITED STATES

View details

Anand Swaminath

juravinski cancer centre mcmaster university hamilton ontario canada

CANADA

View details

Mark Clemons

University of Ottawa

CANADA

View details

Sebastien Hotte

McMaster University

CANADA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Gregory Pond

Research Interests

Make your next move.

Explore related searches

Articles (20)

International consensus-driven recommendations for patient-reported outcome research objectives in early phase dose-finding oncology trials: OPTIMISE-ROR

CYTOSHRINK: A randomized phase II trial of cytoreductive stereotactic hypofractionated radiotherapy with ipilimumab/nivolumab for metastatic kidney cancer.

Relapsing, steroid-refractory ICANS after CAR T-cell therapy: diagnostic work-up and response to delayed repeated intrathecal chemotherapy

Second primary malignancy in multiple myeloma: does a prior malignancy matter?

Contemporary survivorship care patterns for melanoma patients in Ontario, Canada: variability and opportunity

Stereotactic Prostate Cancer Ablative Re‐Irradiation: A Systematic Review and Meta‐Analysis (SPARE)

A Randomized Trial Evaluating Personalized Versus Guideline-Based Well Follow-Up Strategies for Patients with Early Breast Cancer: Feasibility Outcomes

Secondary primary malignancies in indolent non‐Hodgkin lymphoma patients receiving frontline bendamustine‐rituximab

Transfer Learning and Machine Learning for Training Five-Year Survival Prognostic Models in Early Breast Cancer: Development and Validation Study

Prognostic and predictive performance of PREDICT 2.1, PREDICT v3, and RSClin in node-negative early breast cancer: a TEAM pathology substudy

ASO Visual Abstract: Two-Year Outcomes After Direct-to-Surgery in Good Prognosis Margin-Clear Stage II or III Rectal Cancer—The QuickSilver Study

Two-Year Outcomes after Direct-to-Surgery in Good Prognosis Margin-Clear Stage II or III Rectal Cancer: The QuickSilver Study

Pre-operative positron emission tomography scan is associated with lower rates of adjuvant treatment in surgically treated patients with cervical cancer: a 4C Working Group study

Every Six-Month versus Single-Dose Adjuvant Zoledronate in Early Breast Cancer.

Incidence and Management Trends in Advanced Head and Neck Non-Melanoma Skin Cancer in Ontario

Assessment of Risks and Outcomes of Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease in Allogeneic Stem Cell Transplant Recipients Including Potentially Undiagnosed Cases—A Multicenter Canadian Study

Abstract 3956: Spatial transcriptomic mapping of ER-positive breast tumors reveals immune pathway remodeling and resistance mechanisms following anti-PD-1 therapy

Real-world comparison of progression-free survival and time to next therapy in 761 patients with newly diagnosed multiple myeloma

Reconstructive surgery and immigration status among females with breast cancer

Changes in Frailty Categorization Over One Year among Real-World Patients with Multiple Myeloma: A Prospective Cohort Study (MFRAIL)

Collaborators (16)

Aly-Khan A. Lalani

Aaron R. Hansen

Theodoros Tsakiridis

Christina Yap

Fabio Ynoe Moraes

Marie-France Savard

Darryl Leong

Surbhi Sidana

Hsien Seow

Olalekan Lee Aiyegbusi

Gwynivere Davies

John Devin Peipert

Claire Snyder

Anand Swaminath

Mark Clemons

Sebastien Hotte

Make your next move.